The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income ...
LONDON, April 1 (Reuters) - Vaccine makers Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results